Oral administration (swallowed whole with water; take at least 1 hour before or 2 hours after meals, on an empty stomach). Take at approximately the same time each day.
Packaging
Blister pack (PVC-Alu) or HDPE bottle, typically 30 tablets per blister pack or bottle
Storage
Store below 25°C, in a dry place, protected from light and moisture. Keep container tightly closed. Do not freeze.
Shelf Life
36 months (unopened)
Product Overview
Erlotinib Hydrochloride Tablets is an oral preparation containing Erlotinib Hydrochloride equivalent to 150mg of Erlotinib per film-coated tablet. Erlotinib is a targeted therapy agent that selectively inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase. It is used for the treatment of specific types of non-small cell lung cancer (NSCLC) in patients with EGFR mutations, and in combination with other agents for the treatment of pancreatic cancer. The product is formulated as film-coated tablets for convenient once-daily oral dosing.
